FDA OKs Voxelotor for Root Cause of Sickle Cell Disease FDA OKs Voxelotor for Root Cause of Sickle Cell Disease

Voxelotor targets the root cause of sickle cell disease and was granted accelerated approval to treat adults and children aged 12 years and older.FDA Approvals
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news